# Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers

> **NCT02563522** · PHASE3 · TERMINATED · sponsor: **Helixmith Co., Ltd.** · enrollment: 44 (actual)

## Conditions studied

- Foot Ulcer, Diabetic

## Interventions

- **GENETIC:** Engensis (VM202)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02563522
- **Lead sponsor:** Helixmith Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-06-27
- **Primary completion:** 2019-09-24
- **Final completion:** 2019-09-24
- **Target enrollment:** 44 (ACTUAL)
- **Why stopped:** Low enrollment
- **Last updated:** 2025-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02563522

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02563522, "Safety and Efficacy Study of Engensis (VM202) in the Treatment of Chronic Non-Healing Foot Ulcers". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02563522. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*